ArticleCancers2019

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.

Akihiro Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.